Prognostic value of primary tumor uptake on F-18 FDG PET/CT in patients with invasive ductal breast cancer

Nuclear Medicine and Molecular Imaging

Volumn 45, Issue 2, 2011, Pages 117-124

  Song, Bong Il ^a   Hong, Chae Moon ^a   Lee, Hong Je ^a   Kang, Sungmin ^a   Jeong, Shin Young ^a   Kim, Hae Won ^a   Chae, Yee Soo ^a   Park, Ji Young ^a   Lee, Sang Woo ^a   Ahn, Byeong Cheol ^a   Lee, Jaetae ^a  

^a Kyungpook National University Hospital   (South Korea)

Author keywords

F 18 FDG PET CT; Invasive ductal breast cancer; Prognosis; SUVmax

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FLUORODEOXYGLUCOSE F 18; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG UPTAKE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

EID: 79960043304     PISSN: 18693474     EISSN: 18693482     Source Type: Journal    
DOI: 10.1007/s13139-011-0081-0     Document Type: Article

References (22)

1. Desantis C, Center MM, Siegel R, Jemal A. American Cancer Society. Breast Cancer Facts & Figures 2009-2010 Atlanta: American Cancer Society, Inc. http://www.cancer.org/acs/groups/content/@nho/documents/document/f861009final90809pdf.pdf
2. Lavayssière R, Cabée AE, Filmont JE. Positron emission tomography (PET) and breast cancer in clinical practice. Eur J Radiol. 2009;69:50-8.
3. Geus-Oei LF, Oyen WJ. Predictive and prognostic value of FDGPET. Cancer Imaging. 2008;8:70-80.
4. 18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys. 2004;59:1295-300.
5. Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol. 2004;22:3255-60.
6. 18F] fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol. 2005;23:1136-43.
7. Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, Verbeken EK, Deneffe GJ, et al. Prognostic importance of the standardized uptake value on F-18 fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven lung cancer group. J Clin Oncol. 1999;10:3201-6.
8. Nguyen XC, Lee WW, Amin AM, Eo JS, Bang SM, Lee JS, et al. Tumor burden assessed by the maximum standardized uptake value and greatest diameter on FDG-PET predicts prognosis in untreated diffuse large B-cell lymphoma. Nucl Med Mol Imaging. 2010;44:39-44.
9. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007;131:18-43.
10. Minn H, Zasadny KR, Quint LE, Wahl RL. Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET. Radiology. 1995;196:167-73.
11. Ikenaga N, Otomo N, Toyofuku A, Ueda Y, Toyoda K, Hayashi T, et al. Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors. Am Surg. 2007;73:1151-7.
12. 18F-FDG uptake of primary breast cancer lesions. J Nucl Med. 2007;48:1266-72.
13. 18F] fluorodeoxyglucose uptake and prognostic parameters in breast cancer. Br J Surg. 2009;96:166-70.
14. Oshida M, Uno K, Suzuki M, Nagashima T, Hashimoto H, Yagata H, et al. Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18 F]-D-glucose. Cancer. 1998;82:2227-34.
15. 18F-fluorodeoxyglucose positron emission tomography/ computed tomography fusion imaging (18 F-FDG PET/CT) in primary breast cancer. Jpn J Clin Oncol. 2008;38:250-8.
16. 18F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography. J Cancer Res Clin Oncol. 2004;130:273-8.
17. Kawamura T, Kusakabe T, Sugino T, Watanabe K, Fukuda T, Nashimoto A, et al. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer. 2001;92:634-41.
18. Cerfolio RJ, Bryant AS. Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival. Ann Thorac Surg. 2006;82:391-5.
19. Minn H, Lapela M, Klemi PJ, Grénman R, Leskinen S, Lindholm P, et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med. 1997;38:1907-11.
20. Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg. 2005;130:151-9.
21. Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, et al. Comparison of triple-negative and estrogen receptorpositive/ progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/ positron emission tomography imaging parameters: a potentially useful method for disease characterization. Cancer. 2008;112:995-1000.
22. Toikkanen S, Pylkkanen L, Joensuu L. Invasive lobular carcinoma of the breast has better short-and long-term survival than invasive ductal carcinoma. Br J Cancer. 1997;76:1234-40.